Publications and Presentations

Presentations

2016
mrdr poster

  • Z. McQuilten, Putting the pieces together – Epidemiology Practice and Outcomes in Australia and New Zealand, National Myeloma Workshop, Yarra Valley, Vic September 2016
  • K. Bergin et al. Rates of Upfront Autologous Stem Cell Transplantation (ASCT) in Newly Diagnosed Multiple Myeloma (poster), National Myeloma Workshop, Yarra Valley, Vic September 2016
  • E. Moore et al. Renal impairment in myeloma: Characteristics and outcomes in patients with and without renal impairment in the ANZ Myeloma and Related Diseases Registry (poster), National Myeloma Workshop, Yarra Valley, Vic September 2016
  • E. Moore, MRDR: Maturing data, HSANZ Nurses Group, Myeloma Special Practice Network Education Seminar, August 2016
  • E. Moore, MRDR: sustaining growth, Monash SPHPM Registry SIG, June 2016
  • A. Spencer, MRDR presentation to ALLG, ALLG Scientific Meeting, May 2016
  • B. Rosengarten, Myeloma Awareness Day Meeting, Sydney, May 2016

2015

  • A. Spencer, Korean Society of Hematology annual meeting, Seoul, November 2015
  • E. Moore et al., HAA, Adelaide October 2015 (poster)
  • A. Spencer, MRDR Interest Group meeting, HAA, Adelaide, October 2015
  • E. Moore et al., International Myeloma Workshop, Rome, September 2015 (poster)
  • E. Wood, Australian Centre for Blood Diseases (ACBD) and Monash Health Research Symposium, Melbourne 2015

Talks including reference to or introduction of the MRDR:

  • A. Kalff, Binding site Educational Workshop, Melbourne, November, 2015
  • A. Kalff, Myeloma Australia, Medical scientific advisory group (MSAG) meeting, Melbourne, November, 2015
  • T. King, Update from IMW 2015 Rome: Nursing Symposium. HSANZ NG NSW Dinner Meeting. Sydney, November 2015 (poster)
  • T. King, Best practice in the administration of chemotherapy: Bortezomib focus. Tata Memorial Hspt Mumbai; Cancer Institute Chennai; Apollo Hospital Chennai; All India Institute of Medical Sciences (AIMS) Delhi; Rajiv Gandhi Cancer Institute Delhi India, August, 2015
  • A. Kalff, Myeloma Australia, medical scientific advisory group (MSAG) meeting, Melbourne, May, 2015

2014

  • A. Spencer, Myeloma Scientific Advisory Group, Myeloma Foundation Australia, Melbourne, Victoria
  • A. Spencer, MRDR Interest Group Meeting, HAA, Perth, Western Australia, October 2014

Talks including reference to or introduction of the MRDR:

  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Taipei, Taiwan, November 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients with Targeted Therapy. Kaohsiung, Taiwan, November 2014
  • T. King, Making sense of myeloma: An overview of treatment. Leukaemia and Blood Cancer Foundation & HSANZ Nurses Group Educational meeting for nurses, September 2014 
  • T. King, Myeloma: An overview of disease, treatments and management of side effects. Leukaemia and Blood Cancer Foundation Patient and Family Forum Auckland New Zealand, September 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. The First Affiliated Hospital of College of Medicine Zhejiiang University. Hangzhou, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Shanghai Changzheng, Shanghaim, China, February 2014
  • T. King, The Clinical Care of Multiple Myeloma Patients. Institute of Haematology and Blood Diseases Hospital Chinese Academy of Medical Sciences. Tianjin, China, February 2014

2013

  • A. Spencer HAA Investigator Meeting, Gold Coast, Queensland